EDITORIAL


https://doi.org/10.5005/jp-journals-10015-1743
World Journal of Dentistry
Volume 11 | Issue 4 | Year 2020

Telemedicine Approach for Oral Submucous Fibrosis in Coronavirus Disease-2019 Hot Spots


Shailesh Gondivkar1, Sachin Sarode2, Amol Gadbail3, Revant Chole4, Gargi Sarode5, Rima Gondivkar6, Monal Yuwanati7

1Department of Oral Medicine and Radiology, Government Dental College and Hospital, Nagpur, Maharashtra, India
2,5Department of Oral Pathology and Microbiology, Dr DY Patil Dental College and Hospital, Dr DY Patil Vidyapeeth, Pune, Maharashtra, India
3Department of Dentistry, Indira Gandhi Government Medical College and Hospital, Nagpur, Maharashtra, India
4Department of Oral Medicine and Radiology, College of Dental Sciences, Bhavnagar, Gujarat, India
6Independent Researchers, Nagpur, Maharashtra, India
7Department of Surgery, People’s College of Medical Science and Research Centre, People’s University, Bhopal, Madhya Pradesh, India

Corresponding Author: Shailesh Gondivkar, Department of Oral Medicine and Radiology, Government Dental College and Hospital, Nagpur, Maharashtra, India, Phone: +91 9604121273, e-mail: shailesh_gondivkar@yahoo.com

How to cite this article Gondivkar S, Sarode S, Gadbail A, et al. Telemedicine Approach for Oral Submucous Fibrosis in Coronavirus Disease-2019 Hot Spots. World J Dent 2020;11(4):253–254.

Source of support: Nil

Conflict of interest: None

Oral submucous fibrosis (OSF) is a betel quid habit associated with chronic debilitating disease of the oral cavity characterized by inflammation and progressive fibrosis of the oral and oropharyngeal submucosal tissues. It results in marked rigidity of the oral mucosa and an eventual decrease in the oral health-related quality of life due to the inability to open the mouth and burning sensation. In addition to significant morbidity, OSF has the highest malignant transformation rate and associated mortality.1

Among all the oral potentially malignant disorders, OSF was the most prevalent (4.96%; 95% CI = 2.28–8.62) pathology followed by leukoplakia (4.11%; 95% CI = 1.98–6.97). Due to the increase in betel quid consumption among the population, the prevalence rate for OSF is likely to increase in the near future. Since stage II and stage III are symptomatically more unbearable, the majority of these patients usually report to healthcare professionals at this stage. Despite the extensive research on pathogenesis and treatment, no standardized management protocol is still available and it varies from physician to physician.2 Moreover, pharmacological therapies need to be given for longer periods to minimize the symptoms in stage I to stage III patients. As no promising modality is still proved for the complete cure of OSF, careful monitoring with regular follow-up of these patients is essential. This is of utmost importance due to the high malignant transformation rate of OSF.

With the coronavirus disease-2019 (COVID) pandemic, many of the healthcare professionals, institutions, and government agencies are paying the utmost attention to COVID-19 patients. As COVID-19 is highly contagious and can spread via respiratory droplets, healthcare professionals, particularly dentists, otolaryngologists, ophthalmologists, and head and neck surgeons, are at a high risk of infection.3 As an effect of this and a lockdown, many of the patients who are already undergoing treatment for OSF find it difficult to reach to their healthcare professionals specialists for follow-up and treatment continuation. This is even more difficult for OSF patients residing in remote areas with limited healthcare facilities. Thus, there is a high probability of missing out on early detection of oral cancer in OSF patients leading to an advanced stage and poor prognosis. Although the whole world is going through COVID-19 pandemic, serious health concerns such as oral cancer cannot be overlooked at any cost. In the present paper, we have made an effort to discuss some of the options that can be potentially incorporated for the efficient delivery of health care in OSF patients.

In conclusion, considering the increasing prevalence of OSF and its higher malignant potential, oral healthcare professionals should employ newer approaches for continued management of OSF and to identify malignant changes, if any, at an early stage to reduce oral cancer burden.

REFERENCES

1. Gondivkar SM, Bhowate RR, Gadbail AR, et al. Assessment of oral health-related quality of life instruments for oral submucous fibrosis: a systematic review using the consensus-based standards for the selection of health measurement instruments (COSMIN) checklist. Oral Oncol 2019;93:39–45. DOI: 10.1016/j.oraloncology.2019.04.009.

2. Chole R, Gondivkar SM, Gadbail AR, et al. Review of drug treatment of oral submucous fibrosis. Oral Oncol 2012;48(5):393–398. DOI: 10.1016/j.oraloncology.2011.11.021.

3. Vargas M, Servillo G. Improving staff safety during tracheostomy in COVID-19 patients. Head Neck 2020;42(6):1278–1279. DOI: 10.1002/hed.26163.

4. Halboub E, Al-Maweri SA, Al-Soneidar WA. Utilization of COVID-19 testing for opportunistic screening of oral cancer. Oral Oncol 2020;106:104775. DOI: 10.1016/j.oraloncology.2020.104775.

5. Elango KJ, Anandkrishnan N, Suresh A, et al. Mouth self-examination to improve oral cancer awareness and early detection in a high-risk population. Oral Oncol 2011;47(7):620–624. DOI: 10.1016/j.oraloncology.2011.05.001.

6. Shrestha G, Maharajan L. Mouth self-examination for prevention and control of oral cavity cancer. J Nepal Med Assoc 2020;58(225):360–362.

7. Sarode SC, Sarode GS, Gaikwad T, et al. Usage analysis of WhatsApp for dentistry-related purposes among general dental practitioners. J Contemp Dent Pract 2018;19(10):1267–1272. DOI: 10.5005/jp-journals-10024-2415.

8. Sarode SC, Sarode GS, Anand R, et al. WhatsApp is an effective tool for obtaining second opinion in oral pathology practice. J Oral Pathol Med 2017;46(7):513–519. DOI: 10.1111/jop.12515.

9. Prasad A, Carey RM, Rajasekaran K. Head and neck virtual medicine in a pandemic era: lessons from COVID-19. Head Neck 2020;42(6):1308–1309. DOI: 10.1002/hed.26174.

10. Carrard VC, Roxo Goncalves M, Rodriguez Strey J, et al. Telediagnosis of oral lesions in primary care: the EstomatoNet program. Oral Dis 2018;24(6):1012–1019. DOI: 10.1111/odi.12851.

________________________
© The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.